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Abstract: The 5,8-quinolinedione-betulin hybrids were investigated using spectroscopic methods
as well as a variety of quantum chemical calculations in order to characterize their molecular
structure. We used FT-IR and NMR spectroscopy supplemented by the density functional theory
(DFT) calculations, molecular electrostatic potential (MEP) and molecular orbital (HOMO, LUMO)
analyses. The experimental and calculated FT-IR spectra showed a good correlation for all compounds.
Analysis of carbonyl band showed that the compounds are the 7-mono substituted. The calculated
1H NMR and 13C NMR spectra of hybrids reproduced well the experimental ones. Identification
of C-6 and C-7 carbon atoms of 5,8-quinolinedione revealed the position of betulin moiety at the
C-7 of 5,8-quinolinedione. Molecular electrostatic potential maps of hybrids allowed to recognize
the electrophilic and nucleophilic regions within the molecules. The molecular docking study was
used to examine the interaction between the 5,8-quinolinedione-betulin hybrids and the SARS-CoV-2
protein, like: Mpro and PLpro. The obtained results showed that compounds with the highest Dock
Score are good anti-SARS-CoV-2 potential drug candidates.
Keywords: 5,8-quinolinedione; betulin; spectroscopic analysis; molecular docking; SARS-Cov-2
1. Introduction
Compounds with 1,4-quinone moiety and their derivatives are a large class of com-
pounds found in the plant kingdom and as products of secondary metabolism of some
microorganisms and fungi. The occurrence of heterocyclic scaffolds in chemical compounds
facilitates interaction with different molecular targets, which cause a high biological ef-
fect [1,2]. 5,8-Quinolinedione moiety is a combination of 1,4-quinone moiety (ring A)
with the pyridine fragment (ring B) and was found in microorganisms from Streptomyces
species (Figure 1). Chemical modification of 5,8-quinolinedione moiety at the C-6 and
C-7 positions provides derivatives, which exhibit a wide spectrum of biological activity,
including anticancer, antiviral, antibacterial and antimalarial activities [3–6]
Synthetic derivatives of 5,8-quinolinedione are obtained in the reaction between
6,7-dichlor-5,8-quinolinedione and a nucleophilic substance. Commonly, the product
of the reaction is a mixture of two mono-substituted compounds that are difficult to
separate. Moreover, the determination of the substituent position in a pure compound
is complicated [7–10]. The 13C NMR and FT-IR spectroscopy are useful techniques for
determining the substituent position in 5,8-quinolinedione moiety [11–13].
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Figure 1. Structure of 5,8-quinolinedione. 
Synthetic derivatives of 5,8-quinolinedione are obtained in the reaction between 6,7-
dichlor-5,8-quinolinedione and a nucleophilic substance. Commonly, the product of the 
reaction is a mixture of two mono-substituted compounds that are difficult to separate. 
Moreover, the determination of the substituent position in a pure compound is compli-
cated [7–10]. The 13C NMR and FT-IR spectroscopy are useful techniques for determining 
the substituent position in 5,8-quinolinedione moiety [11–13]. 
Continuing our research on alkoxy derivatives of 5,8-quinolinedione, we decided to 
study the 1H NMR and 13C NMR and FT-IR spectra for the 5,8-quinolinedione-betulin hy-
brids. The analysis was supplemented by the density functional theory (DFT) calculations. 
Respiratory tract infections are diseases cause by RNA viruses, including respiratory 
syncytial virus, influenza viruses, rhinoviruses, parainfluenza viruses, human metapneu-
movirus and human coronaviruses [14]. In late 2019, a new strain of the human corona-
virus was identified in China, which was named COVID-19 or SARS-CoV-2 [15,16]. All 
over the world, thousands of people are infected by this virus every day and many of 
them die [15]. Scientists all over the world are working on a new drug and treatment for 
the SARS-Cov-2 disease. Antiviral compounds, such as remdesivir or dexamethasone, are 
used in the treatment of COVID-19 (Figure 2) [17,18]. Since the late 60s, the option to use 
chloroquine as an antiviral has been considered in a wide range of diseases [19] (Figure 
2). Based on the recent announcements of Gao et al. [20], Wang et al. [21], and Colson et 
al. [22], chloroquine may be the first successful attempt to use this drug in the treatment 
of SARS-CoV-2 related diseases. 
  
 
Figure 2. Structure of compounds used in SAR-Cov-2 therapy. 
A library of over 50,000 compounds that could interact with the SARS-CoV-2 protein 
was analyzed [23,24]. The in silico study indicated that triterpenoids could be an inhibitor 
of the COVID-19 protein [25,26]. Zhang et al. conducted in silico research on betulinic acid 
and cryptotanshinone as 3CLpro and PLpro inhibitors [25]. Bevirimat and phosphate de-
rivatives of 3-carboxyacylbetulin (Figure 3) were docked to the active center of the SARS-
CoV-2 protein, like: Mpro (also known as 3CLpro), RdPp, E-protein and S-protein, and 2′-
O-ribosemethyltransferase (MTase) [27,28]. Wen et al. tested diterpenoids (pinusolidic 
acid and forskolin) and triterpenoids (betulinic acid and betulonic acid) in vitro as inhib-
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Figure 2. Structure of compounds used in SAR-Cov-2 therapy.
A library of over 50,000 compounds that could interact with the SARS-CoV-2 protein
was analyzed [23,24]. The in silico study indicated that triterpenoids could be an inhibitor
of the COVID-19 protein [25,26]. Zhang et al. conducted in silico research on betulinic
acid and cryptotanshinone as 3CLpro and PLpro inhibitors [25]. Bevirimat and phosphate
derivatives of 3-carboxyacylbetulin (Figure 3) were docked to the active center of the SARS-
CoV-2 protein, like: Mpro (also known as 3CLpro), RdPp, E-protein and S-protein, and
2′-O-ribosemethyltransferase (MTase) [27,28]. Wen et al. tested diterpenoids (pinusolidic
acid and forskolin) and triterpenoids (betulinic acid and betulonic acid) in vitro as inhibitors
of 3CL protease (Figure 3) [26]. Moreover, Chang et al. conducted a molecular docking
study of 5,8-quinolinedione derivatives, like DA3003-1 (Figure 3). Chang et al. obtained
the crystal structure of HCoV-OC43 bound to the DA300-1 molecule, showing that this
compound can be used as an inhibitor against the Nucleocapsid (N) of SARS-CoV-2 [29].
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Figure 3. Structure of compounds tested as SARS-COV2 protein inhibitor.
Inspired by literature data, the molecular docking study was used to examine the
interaction of Mpro and PLpro proteins with the 5,8-quinolinedione-betulin hybrids.
2. Materials and Methods
2.1. Physical Measurements
Compounds 1–4 (Figure 4) were synthesized according to the methods described
previously [30]. The Fourier Transform Infrared Spectroscopy (FT-IR) spectra were recorded
using the IRAffinity-1 Shimadzu spectrophotometer. The resolution of spectrum was
0.5 cm−1. The sample of each derivative was prepa ed as KBr pellet and measured in the
range of 400–3500 cm−1 at room temperature. The 1H and 13C NMR spectra were m asured
using the Bruker Avance 600 spect ometer. The 10 mg of compounds were dissolved in
0.6 mL of CDCl3.
2.2. Computational Details
The optimized chemistry structure of compounds 1–4 was calculated using the DFT
(B3LYP/6-311G+(d.p)) method implemented in the Gaussian 16 program package [31].
All of the local minima of energy were confirmed by the absence of imaginary mode
invibrational calculations. In our calculations, we applied the basis set with the diffuse
function on heavy atoms (+) to obtain a better description of lone pair electrons with orbitals
occupying a larger region ofspace. The geometry optimization and frequency calculation
for a bigger basis set (6-31++G(d.p) and 6-311+G(d.p)) were also applied but significant
changes in geometry parameters and fundamental frequencies were not observed.
The obtained geometries of compounds 1–4 were used for the calculated the IR, 1H
and 13C NMR spectra. The harmonic vibrational frequencies were calculated at the same
level of theory (B3LYP/6-311G+(d.p)) and the theoretical wavenumbers were scaled by
a factor of 0.964 [32]. The NMR spectra were calculated using the Gauge-Independent
Atomic Orbital (GIAO) method implemented in the Gaussian 16 program package [31,33].
The electrostatic potential V(r) and the electron density maps, which define the molecular
surfaces, were determined [34]. All obtained results were visualized using the GaussView,
Version 5 software package [35].
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Figure 4. Molecular structure of derivatives 1–4.
2.3. Molecular Docking Study
The three-dimensional structures of studied compounds were generated in their
low-energy conformation using the Gaussian 16 (revision A.03) computer code [31] in
the density functional theory (DFT, B3LYP) and 6-311+G(d.p) basis sets. The target
macromolecule for molecular docking studies was obtained from the Protein Data Bank
(https://www.rcsb.org/). We used crystal structures of SARS-CoV-2 main protein (PDB
ID: 5R7Z) and papin-like protease (PDB ID: 6W9C).
In addition, AutoDock Vina [36] was used for the docking analysis. The region of
interest used for Vina docking was fixed as X = −33,784, Y = 20,933, Z = 33,306 for papain-
like protease and X = −11,631, Y = 2201, Z = 23,194 for the COVID-19 main protein. The
volume was set as 25 × 25 × 25 Å. After calculations, only the 9 highest-scored poses were
returned as a docking result for ligand-cavity configuration. All the obtained results were
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ranked according to their score values and presented in kcal/mol. Molecular docking
details were visualized using the BIOVIA Discovery Studio virtual environment [37].
MD simulations for the modeled protein-ligand complexes were performed using
the program NAMD (NAnoscale Molecular Dynamics program; v 2.13) [38] and all files
were generated using visual molecular dynamics (VMD) [39]. Parameterization of the
ligands was performed in the CGenFF server. The parameterized ligands were inserted
into the protein and saved in the form of a protein-ligand complex by VMD with the
binding pocket residues. Then, the protein-ligand complex was immersed in the center
of a 155.3 Å box of water molecules for Mpro and 147.8 Å box of water molecules for
PLpro with a TIP3P water box. The 0.15 M ions (Na+ and Cl−) were added to provide
charge neutralization and electrostatic screening. CHARMM (Chemistry at HARvard
Macromolecular Mechanics) 36 parameter file for proteins and lipids; phi and psi cross-
term map corrections were used in the force field for proteins with similar chemical
structures. For the minimization and equilibration of the complexes in the water box, we
assumed force-field parameters excluding scaling of 1.0 Å. All atoms, including those of
hydrogen, were illustrated explicitly. The hydrogen atom coordinates of proteins were
generated using the VMD Tk-Console salvation command. Integrator parameters also
included 2 fs/step for all rigid bonds and nonbonded frequencies were selected for 1 Å. Full
electrostatic evaluations for 2 Å were used, with ten steps for each cycle. The complexes’
preliminary energy was minimized using 2000 steps of the Powell algorithm at a constant
temperature (310 K), followed by simulation of an additional 144,000 steps with Langevin
dynamics to control the kinetic energy, temperature, and/or pressure of the system. Finally,
the solvated protein-ligand complex system was equilibrated with 50,000 minimization
steps and production runs with 5,000,000 steps (10 ns) were than performed.
Results were analyzed using the Visual Molecular Dynamics package (VMD,
https://www.ks.uiuc.edu/research/vmd/) [40].
3. Results and Discussion
3.1. Molecular Geometry
Molecular structures with numbering of atoms for compounds 1–4 are presented
in Figure 4. Tables S1–S4 present the calculated bond lengths and angles for 1–4. The
bond lengths of the C-C in betulin moiety are typical for a single bond, while the bond
lengths of C-C, C-O and C-N in 5,8-quinolinedione moiety are intermediate between
single and double bond lengths. These results also showed the π delocalisation for the
5,8-quinolinedione ring [41,42]. Comparing the orientation of 5,8-quinolinedione in relation
to betulin moiety, it can be seen that they have a similar arrangement in the following pairs
1–2 and 3–4 (Tables S1–S4).
3.2. FT-IR Spectra
The both experimental and calculated FT-IR spectra for compounds 1–4 are presented
in Figures 5 and 6 and their assignments are entered in Table 1. The band assignment
of experimental FT-IR spectra was carried out on the basis of theoretically predicted
vibrations by DFT method. Generally, for all compounds, the theoretical spectra reproduce
the experimental ones well.
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Table 1. Band assignments of experimental and calculated IR spectra for studied compounds 1–4.
Assignment
1 2 3 4
Exp Calc Exp Calc Exp Calc Exp Calc
v C≡C-H 3330–3258 3361
v OH 3418 3621
v aliphatic CH3, CH2,
CH 3073–2870 3119–2841 3070–2872 3119–2942 3073–2870 3120–2856 2945–2870 3118–2858
v C≡C 2115 2138
v OC=O 1728 1777 1736 1785 1712 1747
vas C=O 1691 1704 1691 1700 1693 1700 1668 1704
vs C=O 1674 1688 1670 1690 1668 1685 1639 1687
vs C=C isopropenyl 1637 1670 1641 1669 1641 1670 1637 1666
v aromatic C-C, C-H 1593–1566 1583–1557 1593–1562 1584–1533 1589–1558 1577–1546 1591–1558 1574–1548
σ aliphatic CH3, CH2,
CH 1458 1479 1465 1477 1462 1448 1463 1478
ν CH3, CH2 1388–1311 1392–1288 1373–1315 1369–1291 1369–1314 1373–1292 1388–1311 1409–1288
ν C-N 1278 1288 1280 1291 1278 1291 1274 1288
δ C-C, C-H 1246 1235 1251–1240 1230 1251 1238–1222 1252–1224 1236–1201
ν C-C, C-H 1182–1149 1166–1132 1182–1149 1168–1130 1184–1148 1168–1130 1182–1148 1166–1131
δ C-C, C-H 1096–1064 1053 1093–1022 1052–1006 1064–1035 1153–1052 1093–1043 1056–1029
ν C-O 1045–1020 1027–1010 1024 1021–1007 1033–1020 1037–1006 1018 1018–1001
ν C-O 945–927 923 945–933 921 910 916 974 958
δ C-C, CH3, CH2, CH 880–856 880–854 900–852 875–852 883–856 875–862 883–856 880–862
v C-Cl 815 828 813 829 812 829 812 828
v C-C C-H 754–725 741–706 734–704 736–705 726–690 737–705 754–723 732–706
3.2.1. C-H and C-C Vibration
Compounds 1–4 contain aromatic and aliphatic C-H groups, which exhibit stretching
vibrations in the ranges of 3073–2870 cm−1 and 1388–1288 cm−1. The absorption peak at the
1641–1637 cm−1 is attributed to the C=C stretching vibration of the isopropenyl group at
C-19 position of betulin moiety. Stretching vibration in the range of 1593–1558 cm−1 refers
to C-C and C-H vibrations of the aromatic group of 5,8-quinolinedione moiety (Figure 5).
The strong band at 1478–1448 cm−1 is assigned to the deformation vibration of C-H in
the methyl groups of betulin. The C-H and C-C bend vibrations in the aliphatic group of
betulin moiety occur in the ranges of 1251–1064 cm−1 and 1252–1052 cm−1 for experimental
and calculated spectra, respectively.
Additionally, for derivative 4, the band resulting from the vibration of the acetylenic
group at the C-28 position of betulin moiety is observed. According to the literature [43],
the double peak in the region of 3298–3277 cm−1 is assigned to the C≡CH stretch vibration.
Moreover, the band at 2121 cm−1 is assigned to the C≡CH aliphatic stretching vibrations
(Figure 5d).
3.2.2. C-O and O-H Vibration
According to the literature [43,44], the absorption peaks in the range of 1045–1000 cm−1
refer to the asymmetric stretching vibrations of C-O groups. In the calculated spectra, two
separate peaks relating to the vibration of the C-O-C group at the C-28 and C-3 positions of
betulin are observed in this region. In the experimental spectra of 1 and 3, two separate
peaks are observed, while, for 2 and 4, broad peak at 1024 cm−1 and 1018 cm−1 are observed,
respectively. Furthermore, the symmetric stretching vibrations of the C-O group at 980–
910 cm−1 are observed [43,44]. The symmetric stretching vibrations of the C-O-C group
between betulin and 5,8-quinolinedione moieties at the 958–916 cm−1 and 974–916 cm−1 in
calculated and experimental spectra are observed, respectively. In experimental spectra of
compounds 1 and 2 containing 5,8-quinolinedione moiety at the C-28 position of betulin,
peaks of the C-O-C vibration split into two separated peaks. According to the literature,
this observation may suggest the formation of weak hydrogen bonds [43–45].
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Additionally, compound 1 has a hydroxy group at the C-3 position of betulin, for
which the absorption peaks are observed at 3418 cm−1 and 3621 cm−1 in experimental and
calculated spectra, respectively.
3.2.3. C=O Vibration
Compound 1 contains two carbonyl groups at the C-5 and C-8 positions of 5,8-
quinolinedione moiety (Table 1). According to the literature, in the region of 1638–1704 cm−1,
the asymmetric and symmetric vibrations of the carbonyl group at C-8 and C-5 position of
5,8-quiolinedione moiety can be observed, respectively (Figure 6a) [7,11,46]. Comparison
of experimental and calculated spectra shows that experimental bands are shifted towards
lower wavenumbers. As seen in Table 1, the frequency separation ∆ν = νas − νs of the
carbonyl bands in the experimental and calculated spectra for 1 are equal to 17 cm−1 and
36 cm−1, respectively. As can be found in the literature [11,12], the splitting of the carbonyl
band indicates that the compounds are 7-mono substituted.
The molecular structure of hybrid 2 differs from 1 in terms of the presence of the acyl
group at the C-3 position of betulin moiety (Table 1). In FT-IR experimental and calculated
spectra of 2, the carbonyl and carboxyl bands are observed in the ranges of 1670–1728 cm−1
and 1690–1777 cm−1, respectively. In the experimental spectrum, the band of the carboxyl
group of betulin moiety is shifted towards lower frequencies compared to the calculated
one, i.e., from 1777 cm−1 to 1728 cm−1 (Figure 6b). In the experimental spectrum, the
position of carbonyl bands in 5,8-quinoliedione are similar to those in hybrid 1 and the
frequency separation is equal to 26 cm−1. In the calculated spectrum, the carbonyl bands
are close to each other and the ∆ν is equal to 10 cm−1 (Table 1, Figure 6).
Hybrids 3 and 4 contain 5,8-quinolinedione moiety at the C-3 position of betulin and
acyl or propynoil group at the C-28 position. The calculated spectra of both compounds
are similar, which means that the stretching vibration of the carboxyl group is attributed to
peak at 1747 cm−1, while the asymmetric and symmetric stretching vibrations of carbonyl
groups are observed in the range of 1666–1687 cm−1. In experimental spectra of both
compounds, the carboxyl group band is observed at 1712 cm−1 (Figure 6c,d). However,
in the spectrum of 4 the carboxyl peak is broad, which could suggest the formation of a
hydrogen bond.
Introduction of carboxyl group at C-28 position of betulin moiety influences the shift
of the carbonyl band toward lower frequencies. For hybrid 3, the experimental frequencies
of the carbonyl bands are similar to those for 2, i.e., 1668 cm−1, 1693 cm−1 and 1670 cm−1,
1691 cm−1, respectively (Figure 6b,c). As seen in Figure 6d, for compound 4, the asymmetric
and symmetric stretching vibrations are localized at 1668 cm−1 and 1639 cm−1, respectively.
For hybrid 4, the experimental and calculated frequency shifts ∆ν are equal to 29 cm−1 and
21 cm−1, respectively.
3.2.4. C-N Vibration
The C-N band vibration in the FT-IR spectra is difficult to identify because these
bands are observed at the same region as the C-C and C-H bands of aromatic com-
pounds [13,43,44]. According to literature, for aromatic compounds, the C-N stretching
vibration is observed in the range 1266–1382 cm−1 [44]. In the presented study, the band
at 1274–1280 cm−1 and 1288–1291 cm−1 in the experimental and calculated spectra are
attributed to the stretching C-N vibration (Table 1).
3.2.5. C-Cl Vibration
According to literature data, the C-Cl stretching vibrations show strong bands in the
region of 760–505 cm−1 [43,44]. In our experiment, the computed and experimental C-Cl
bands are observed at 812–815 cm−1 and 828–829 cm−1, respectively (Table 1).
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3.3. 1H and 13C NMR Study
Hybrids 1–4 were characterized by 1H and 13C NMR spectra and the corresponding
chemical shifts were simulated by the GIAO method using the optimised limitations from
the 6-311+G(d.p) basis set [45,46]. The hybrids 1–4 contain more than 50 protons and
30 carbon atoms. Of these, the more important protons and carbon atoms were selected
for analysis. The both experimental and calculated chemical shifts for the selected peak
of compounds 1–4 are presented in Table 2. Figures S1–S8 present the experimental and
calculated 1H and 13C NMR spectra for all derivatives 1–4.
Table 2. The experimental and calculated chemical shifts in 1H NMR and 13C NMR spectra for selected atoms of hybrids 1–4.
Atoms
1 2 3 4
Exp Calc Exp Calc Exp Calc Exp Calc
H-2q 9.07 9.19 9.06 9.11 9.04 9.13 9.04 9.09
H-4q 8.50 8.35 8.50 8.23 8.50 8.25 8.50 8.26
H-3q 7.73 7.36 7.73 7.31 7.71 7.27 7.72 7.27
H-28Abet 4.87 4.79 4.88 4.70 4.28 5.14 4.40 4.17
H-29Abet 4.71 5.09 4.71 5.01 4.71 4.99 4.72 4.87
H-29Bbet 4.62 4.72 4.62 4.60 4.61 4.52 4.62 4.92
H-28Bbet 4.29 3.94 4.28 3.82 3.88 3.28 4.00 3.76
H-3bet 3.21 3.50 4.49 4.76 4.81 4.78 4.81 4.74
H-19bet 2.44 2.48 2.43 2.49 2.47 2.34 2.45 2.38
CH3C(O)O - - 2.06 2.02 2.09 2.05 - -
CHCC(O)O - - - - - - 2.91 2.57
C-5q 178.2 181.8 178.2 181.5 178.1 181.9 178.1 181.9
C-8q 177.7 181.6 177.8 180.6 177.9 181.3 177.6 181.4
C-7q 158.1 156.1 158.2 155.3 158.3 156.9 158.1 156.9
C-2q 154.6 155.3 154.7 153.9 154.8 153.1 154.5 153.7
C-20bet 150.1 154.2 150.1 153.2 150.1 152.6 153.3 153.5
C-8Aq 146.6 143.4 146.8 143.2 146.6 143.5 149.9 143.0
C-4q 134.8 132.4 134.9 131.6 134.8 131.7 134.9 131.7
C-6q 131.5 137.7 129.0 137.4 129.1 137.8 128.9 138.1
C-4Aq 128.2 125.6 128.2 124.7 128.2 124.8 128.1 125.2
C-3q 128.1 125.1 127.8 124.5 127.8 124.6 127.8 124.8
C-29bet 110.1 110.8 109.9 109.8 109.9 109.8 110.0 110.4
C28bet 79.0 80.1 80.8 81.2 73.9 64.6 74.6 72.1
C-3bet 73.9 76.8 74.0 79.1 80.9 99.2 92.6 98.7
C(O)O - - 170.9 180.3 171.0 180.2 169.4 162.6
CH3C(O)O - - 16.1 15.5 15.8 15.2 - -
CHCC(O)O - - - - - - 74.8 75.6
CHCC(O)O - - - - - - 74.7 72.2
The calculated 1H NMR spectra of compounds 1–4 reproduce the experimental ones
well (Figure 7a) and the correlation coefficients are in the range of 0.986–0.995.
Comparison of experimental and calculated 1H NMR spectra of 1–4 shows the differ-
ences in values of proton signals in the range of 4.17–5.15 ppm. According to literature
data [47–49], the signals of protons at the H-29 position of betulin are singlet, while signals
of H-28 protons are dublet. The analysis of experimental 1H NMR shows that H-29A and
H-29B protons are observed at 4.28–4.87 ppm and 4.62–4.61 ppm, respectively, while two
dublet signals of H-28 (A and B) protons are observed at 4.88–4.40 ppm and 3.88–4.29 ppm,
respectively. In the calculated 1H NMR spectra, the signal of the H-29A proton is at 4.87–
5.09 ppm, while H-28A is at 4.17–5.14 ppm. For all compounds, the calculated signal of
H-29A is at higher chemical shift than H-28A (Table 2).
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of the comparison of the experimental and calculated spectra (Table 2). The calculated 13C 
NMR spectra reproduce the experimental ones well and their correlation coefficients are 
in the range 0.989–0.996 for 1–4 (Figure 7b). Identification of the chemical shift for carbon 
atoms at C-6 and C-7 of 5,8-quinolinedione moiety allows to determine the position of the 
substituent in 5,8-quinolinedione. In the experimental spectra of compounds 1–4, the sig-
nal of C-6 carbon in 5,8-quinolinemoiety is shifted toward lower chemical shifts than in 
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Figure 7. The linear regression between the experimental liquid and calculated 1H NMR (a) and 13C NMR (b) and chemical
shifts of hybrids 1–4.
The 5,8-quinolinedione moiety contains only three protons in the pyridine ring, which
prevents the use of 2D NMR spectra to analyse the carbon atoms in heterocyclic moiety.
The carbon atoms in 5,8-quinolinedione moiety were assigned signals on the basis of
the comparison of the experimental and calculated spectra (Table 2). The calculated 13C
NMR spectra reproduce the experimental ones well and their correlation coefficients are
in the range 0.989–0.996 for 1–4 (Figure 7b). Identification of the chemical shift for carbon
atoms at C-6 and C-7 of 5,8-quinolinedione moiety allows to determine the position of
the substituent in 5,8-quinolinedione. In the experimental spectra of compounds 1–4, the
signal of C-6 carbon in 5,8-quinolinemoiety is shifted toward lower chemical shifts than
in calculated ones. The signals of C-7 carbon are observed at 158.1–158.3 ppm and 155.3–
158.3 in the experimental and calculated spectra, respectively. The good reproducibility of
these two signals in experimental and calculated spectra confirms that hybrids 1–4 contain
betulin moiety at the C-7 position of 5,8-quinolinedione moiety.
3.4. Frontier Molecular Orbitals
Frontier molecular orbitals theory describing HOMO and LUMO orbitals is useful for
determining the energy distribution and energetic behaviour of a molecule. The HOMO
and LUMO energies denote the ability of molecules to donate and acquire an electron,
respectively [50]. The energy gap (EHOMO-ELUMO) makes it possible to designate the kinetic
stability and reactivity of a compound [13,46,50,51]. The HOMO and LUMO orbitals and
its energy gap was calculated in the Gaussian09 package at the B3LYP level using the
6-311G+(d.p) basis set [31].
As seen in Figure 8, the isocontour of the HOMO orbital of all compounds are mainly
delocalized on the isopropenyl group and E ring of betulin moiety. The energy of the
HOMO orbital (EHOMO) is within the range of (−6.605 to −6.839) eV meaning that the
molecules are low reactive with the electrophilic molecule [50]. The LUMO orbital is
delocalized on 5,8-quinolinedione moiety and its energy shows that compounds 1–4 are
high reactive against the nucleophilic molecule [50]. The negative energy of HOMO and
LUMO orbitals shows that the compounds are stable. For hybrids 1–4, the large HOMO–
LUMO energy gap varies in the range of (−3.015 to −3.125) eV, and this can be related
to some molecular hardness and less polarizability. According to literature data [52,53],
the van der Waals interactions between two molecules depends on energy gap ∆E and its
value could be correlated with the biological activity of the compound. The ∆E energy gap
for compounds 1–4 has low value, suggesting possible interactions between hybrids and
proteins responsible for their biological activity (Table 3, Figure 8).
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3.5. Molecular Electrostatic Potential
The molecular electrostatic potential (MEP) provides knowledge about the arrange-
ment of the positive and negative charge of the molecule. The colours on the MEP surface
represent different values of the electrostatic potential. The most negative and positive
regions are represented by red and blue, respectively [55]. The MEP maps of hybrids 1–4
were calculated using the DFT/B3LYP level using the 6-311G+(d.p) basis set and they are
sketched for an order of −44.3774 kcal/mol to 44.3774 kcal/mol. The calculated MEP maps
for hybrids 1–4 are presented in Figure 9a–d.
For all compounds 1–4, the nucleophilic regions (red colour) are localized in three
main areas. The first area contains a nitrogen atom, carbonyl group at the C-8 position and
an oxygen atom at C-7 position of 5,8-quinolinedione moiety. The second and third area
includes the carbonyl group at the C-5 position, and the hydroxy (1) or carboxyl group
(2–4) of betulin moiety, respectively (Figures S9–S12).
For all hybrids, in the first area, following two potential minima are observed: −(2.72–
2.88) eV and −(2.07–2.18) eV. In second area near carbonyl group at C-5 position of 5,8-
quinolinedione moiety the potential minimum is equal −(2.18–2.29) eV. For hybrid 1, in
third area only one potential minimum (−2.99 eV) can be observed. For hybrid with acyl
group (2–4) two potential minima: −(2.19–2.45) eV and −(1.63–1.74) eV at this areas are
observed. The negative region could be involved in the formation of a hydrogen bond with
some biological targets.
The electrophilic regions (blue colour) are localized near hydrogen atoms of 5,8-
quinolinedione. Additionally, in hybrid 4, the positive region is situated on a hydrogen
atom of propynoil group. The light green colour region containing the betulin scaffold is
charge neutral.
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3.6. Molecular Docking
In this study, we use the AutoDock Vina program (referred to as Vina) in in silico
research. As a molecular target, we use two main SAR-CoV-2- polymerase, named Mpro
and PLpro. We used dexamethasone, remdesivir, and chloroquine as reference ligands.
The tested compounds ranked by AutoDock Vina are shown in Table 4. The lowest scores
of binding energy (kcal/mol) of protein-ligand complexes correspond to a strong binding
affinity, and the most probable ligand-protein system in vivo.











Results obtained in the Vina program indicate that all tested compounds show lower
binding energy with Mpro and PLpro compared to the reference dexamethasone, remde-
sivir and chloroquine (Table 4).
As in other coronaviruses, the main protease plays an important role in viral matura-
tion by processing many polyproteins that are translated from the viral RNA.
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According to the crystallographic data, amino acids His 41, His 164, Met 49, Met
165, Thr 190, and Gly 143 play an important role in stabilizing the ligand-Mpro com-
plexes [56,57]. Figures 10a and 11 and Table 5 present the possible interaction of the best
scored compound 4 inside the binding pocket of Mpro.
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Table 5. Interaction of hybrids 4 and 1 with active sites of Mpro and PLpro, respectively. 
Protein Ligand Interaction 




carbonyl oxygen at C-8q conventional hydrogen bond 2.40 
Gly143 carbonyl oxygen at C-8q carbon hydrogen bond 2.85 
Thr26 pyridine ring π-donor 3.11 
Thr25 1,4-quinone ring π-sigma 2.92 
Cys145 C-2 alkyl-alkyl 4.72 
Pro168 cyclopentane ring alkyl-alkyl 5.13 
Cys145 C-24 alkyl-alkyl 4.43 
Cys145 C-25 alkyl-alkyl 5.20 
Met49 1,4-quinone ring alkyl-alkyl 5.13 
Met165 C-29 alkyl-alkyl 5.10 
Leu167 C-29 alkyl-alkyl 5.48 
His41 C-2 π-orbitals 5.36 




carbonyl oxygen at C-8q carbon hydrogen bond 2.77 
Glu167 pyridine ring π-anion 3.78 
Met206 C-7 alkyl-alkyl 5.24 
Met206 C-16 alkyl-alkyl 5.19 
Val202 C-27 alkyl-alkyl 5.06 
Tyr207 C-23 π-alkyl 4.74 
Tyr207 C-24 π-alkyl 4.58 
Figure 11 presents the possible interaction of compound 5 inside the binding pocket 
of Mpro after 2D analysis using the Discovery Studio Visualizer. 
The corresponding amino acids that are significantly involved in the hydrophobic 
interactions are as follows: Thr25 (π-sigma), Thr26 (π-donor), His41 (π-orbitals), Met49, 
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carbonyl oxygen at C-8q carbon hydrogenbond 2.77
Glu167 pyridine ring π-anion 3.78
Met206 C-7 alkyl-alkyl 5.24
Met206 C-16 alkyl-alkyl 5.19
Val202 C-27 alkyl-alkyl 5.06
Tyr207 C-23 π-alkyl 4.74
Tyr207 C-24 π-alkyl 4.58
Figure 11 presents the possible interaction of compound 5 inside the binding pocket
of Mpro after 2D analysis using the Discovery Studio Visualizer.
The corresponding amino acids that are significantly involved in the hydrophobic
interactions are as follows: Thr25 (π-sigma), Thr26 (π-donor), His41 (π-orbitals), Met49,
Cys145, Met165, Leu167, Pro168 (alkyl-alkyl). Generally, strong hydrogen bond interaction
(with donor-acceptor distance of 2.40 Å) between Gly143 and carbonyl oxygen atoms
increases the stability of the ligand-receptor complex.
Molecular dynamics (MD) calculation provides a better understanding of structure-
function relationships in motion and other conformational changes by the proteins. There-
fore, an MD study was conducted in this paper to evaluate the dynamic behavior of the
top-scoring complexes for a period of 10 ns. Analyzing the complexes ligand root-mean-
square deviation (RMSD) and hydrogen bonding can provide insights into a structural
conformation faced by the protein and ligand during simulation (Figure 12, Figure 13 and
Figure 15).
Mpro has the most optimal RMSD profile with a medium value below 2 Å (average
value 1.448 Å). Hybrid 4, during the first 7 ns of simulation, maintains a constant value,
but then it quickly raises RMSD to a value of 0.9 Å, and stabilizes at an RMSD value of
0.5 Å (average value 0.506 Å).
The data shown in Figure 13 shows the results of analysis of hydrogen bond contacts
in the studied complexes. The compound 4 forms two hydrogen bonds, and the binding
with Gly146 residue occurs in the complex at the 28% time of measurement.
PLpro is responsible for processing non structural proteins Nsp1, Nsp2 and Nsp3,
which are released after the cleavage of the N-terminus of the replicas polyprotein. In
addition, the binding site contained S3/S4 pockets (residues Asp164, Val165, Arg166,
Glu167, Met 208, Ala246, Pro247, Pro248, Tyr 264 and Gly266) [58].
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Figures 10b and 14 and Table 5 presents the possible interaction of the top docked pose
of 1 inside the binding pocket of COVID-19 PLpro. The corresponding amino acids that
are signific ntly inv lved in the hydro h bic interactions are as follows: Glu167 (carbon
hydrogen bond, π-anion), Val202, Met206 (alkyl-alkyl), Tyr207 (π-alkyl).
The plots for PLpro Cα versus time for the simulation with compound 1 are shown
in Figure 15. The visual analysis of the trajectory confirms the stability of the structure of
the protein at around 6 ns. The compound 1 has the most optimal RMSD profile with a
medium value below 1 Å (average value 0.727 Å). These results indicate, that compounds
possessing the highest Dock Score (1 and 4) are good anti-SARS-CoV-2 drug candidates.
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4. Conclusions
The various spectroscopic investigations and computational analysis enabled the
examination of th 5,8-quinol edione-betuli hybrids 1–4 as c didates for interaction
w th SARS-CoV-2.
The experimental and calculated FT-IR spectra demonstrated a good correlation for all
compounds. The most significant difference in the FT-IR spectra of hybri s 1–4 occurred in
the regi n of the carbonyl ba ds. The type of substituent impact d the frequency position
and separation f the carbonyl bands ∆ν.
The com uted HOMO and LUMO energy gap supported the possibility of hybrids
to be che ically active, as they are high reactive against nucleo hilic molecules. The
molecular electrostatic potential (MEP) maps showed that the negative potential sites are
present in the electronegative atoms, i.e., nitrogen and oxygen atoms.
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The molecular docking study showed that hybrids 1–4 were locked onto the COVID-19
proteins with a lower negative dock energy than the reference compounds. The lower neg-
ative dock energies were obtained for the Mpro–hybrid 4 and PLpro–hybrid 1 complexes.
Using the molecular dynamics simulation for these two complexes, the stability of the
docking pose was determined. On the whole, the obtained results show that compounds
possessing the highest Dock Score are good potential anti-SARS-CoV-2 drug candidates.
However, further experimental studies are necessary to validate these findings.
Supplementary Materials: The following are available online at https://www.mdpi.com/2073-4
352/11/1/76/s1, Figure S1: The experimental (a) and calculated (b) 1H NMR chemical shifts of
hybrid 1, Figure S2: The experimental (a) and calculated (b) 13C NMR chemical shifts of hybrid
1, Figure S3: The experimental (a) and calculated (b) 1H NMR chemical shifts of hybrid 2, Figure
S4: The experimental (a) and calculated (b) 13C NMR chemical shifts of hybrid 2, Figure S5: The
experimental (a) and calculated (b) 1H NMR chemical shifts of hybrid 3, Figure S6: The experimental
(a) and calculated (b) 13C NMR chemical shifts of hybrid 3, Figure S7: The experimental (a) and
calculated (b) 1H NMR chemical shifts of hybrid 4, Figure S8: The experimental (a) and calculated (b)
13C NMR chemical shifts of hybrid 4, Figure S9: Color-coded computer graphic representation of the
electrostatic potentials for hybrid 1. The positions of the potential minima (in eV) are indicated, Figure
S10: Color-coded computer graphic representation of the electrostatic potentials for hybrid 2. The
positions of the potential minima (in eV) are indicated, Figure S11: Color-coded computer graphic
representation of the electrostatic potentials for hybrid 3. The positions of the potential minima (in eV)
are indicated, Figure S12: Color-coded computer graphic representation of the electrostatic potentials
for hybrid 4. The positions of the potential minima (in eV) are indicated. Table S1: Geometric
parameters (bond length and angles) for hybrid 1 (Å, º), Table S2: Geometric parameters (bond length
and angles) for hybrid 2 (Å, º), Table S3: Geometric parameters (bond length and angles) for hybrid 3
(Å, º), Table S4: Geometric parameters (bond length and angles) for hybrid 4 (Å, º).
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3. Kadela-Tomanek, M.; Bębenek, E.; Chrobak, E.; Boryczka, S. 5,8-Quinolinedione scaffold as a promising moiety of bioactive
agents. Molecules 2019, 24, 4115. [CrossRef]
4. Bayrak, N. Novel azanaphtoquinone compounds with aromatic amino moiety:Synthesis, structural characterization, and
antimicrobial features. J. Mol. Struct. 2019, 1195, 411–416. [CrossRef]
5. Bolzán, A.; Bianchi, M. Genotoxicity of streptonigrin: A review. Mutat. Res. 2001, 488, 25–37. [CrossRef]
6. Boger, D.; Yasuda, M.; Mitscher, L.; Drake, S.; Kitos, P.; Thompson, S. Streptonigrin and lavendamycin partial structures. Probes
for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones. J. Med. Chem. 1987,
30, 1918–1928. [CrossRef]
Crystals 2021, 11, 76 21 of 22
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